Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 25;14(3):33639.
doi: 10.52965/001c.33639. eCollection 2022.

Treatment options for secondary osteonecrosis of the knee

Affiliations

Treatment options for secondary osteonecrosis of the knee

Hassan Zmerly et al. Orthop Rev (Pavia). .

Abstract

Knee osteonecrosis is a debilitating progressive degenerative disease characterized by subchondral bone ischemia. It can lead to localized necrosis, tissue death, and progressive joint destruction. For this reason, it is essential to diagnose and treat this disease early to avoid subchondral collapse, chondral damage, and end-stage osteoarthritis, where the only solution is total knee arthroplasty. Three types of knee osteonecrosis have been documented in the literature: spontaneous or primitive, secondary, and post arthroscopy. Spontaneous osteonecrosis is the most common type studied in the literature. Secondary osteonecrosis of the knee is a rare disease and, unlike the spontaneous one, involves patients younger than 50 years. It presents a particular set of pathological, clinical, imaging, and progression features. The management of secondary osteonecrosis is determined by the stage of the disorder, the clinical manifestation, the size and location of the lesions, whether the involvement is unilateral or bilateral, the patient's age, level of activity, general health, and life expectancy. This review aims to present the recent evidence on treatment options for secondary osteonecrosis of the knee, including conservative treatment, joint preserving surgery, and knee replacement.

Keywords: arthroplasty; joint preservation surgery; knee; mesenchymal stem cells; secondary osteonecrosis.

PubMed Disclaimer

Conflict of interest statement

The authors declared no conflict of interest.

Figures

None
Figure 1. Secondary osteonecrosis of femoral lateral condyle treated arthroscopically by debridement, bone marrow stimulation and implant of scaffold. (A) X-ray plain. (B) MRI image showing epiphysis involvement. (C) Arthroscopic view of lesion. (D) Post-treatment arthroscopic view.
None
Figure 2. SON evolved into end-stage osteoarthritis. (A) X-ray plain. (B and C) MRI image showing knee osteoarthritis and involvement of epiphysis and metaphysis. (D) Patient treated with TKA.

References

    1. 1. Wong SW, Steeples LR, Jones NP. Avascular Necrosis of Bone in Patients with Uveitis Treated with Systemic Corticosteroids. Ocul Immunol Inflamm. Published online February 4, 2021:1-7. doi:10.1080/09273948.2020.1844903 - PubMed
    1. 2. Mont MA, Baumgarten KM, Rifai A, Bluemke DA, Jones LC, Hungerford DS. Atraumatic Osteonecrosis of the Knee. J Bone Joint Surg Am. 2000;82(9):1279-1290. doi:10.2106/00004623-200009000-00008 - PubMed
    1. 3. Wilson C, Marappa-Ganeshan R. Secondary Osteonecrosis of the Knee. In: StatPearls (Internet). StatPearls Publishing; 2021. - PubMed
    1. 4. Karim AR, Cherian JJ, Jauregui JJ, Pierce T, Mont MA. Osteonecrosis of the knee: review. Ann Transl Med. 2015;3(1):6. doi:10.3978/j.issn.2305-5839.2014.11.13 - PMC - PubMed
    1. 5. Chang C, Greenspan A, Gershwin ME. The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis. J Autoimmun. 2020;110:102460. doi:10.1016/j.jaut.2020.102460 - PubMed